Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.09
-0.0500-0.18%
Post-market: 27.07-0.0200-0.07%17:51 EST
Volume:32.60M
Turnover:881.50M
Market Cap:154.03B
PE:19.92
High:27.29
Open:27.06
Low:26.73
Close:27.14
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.91
T/O Rate:0.57%
Dividend:1.72
Dividend Rate:6.35%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.58%
ROA:5.19%
PB:1.66
PE(LYR):19.86

Loading ...

NYSE Most Active Issues

Dow Jones
·
Feb 21

Pfizer Initiated at Underweight by Barclays

Dow Jones
·
Feb 20

Pfizer (PFE) Gets a Hold from Goldman Sachs

TIPRANKS
·
Feb 20

Barclays Initiates Coverage on Pfizer With Underweight Rating

MT Newswires Live
·
Feb 20

Mixed options sentiment in Pfizer with shares down 0.2%

TIPRANKS
·
Feb 19

Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study

TIPRANKS
·
Feb 19

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

Mubadala Investment Co Pjsc Reports Share Stake of 444,978 Shares in Pfizer Inc - SEC Filing

THOMSON REUTERS
·
Feb 17

Pfizer Reports BRAFTOVI Regimen Improves Progression-Free Survival in BRAF V600E-Mutant Metastatic Colorectal Cancer

Reuters
·
Feb 17

Pfizer’s Braftovi Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

THOMSON REUTERS
·
Feb 17

Rothschild & Co Redburn Adjusts Price Target on Pfizer to $25 From $23, Maintains Neutral Rating

MT Newswires Live
·
Feb 17

Pfizer Targets Real‑World Proof for Ritlecitinib in Severe Alopecia Areata

TIPRANKS
·
Feb 14

Pfizer Advances VESPER-5 Obesity and Diabetes Trial, Targeting a Key Growth Market

TIPRANKS
·
Feb 14

Mixed options sentiment in Pfizer with shares down 0.38%

TIPRANKS
·
Feb 13

Daiwa Securities Downgrades Pfizer to Neutral From Outperform, Price Target is $27

MT Newswires Live
·
Feb 12

Pfizer downgraded to Neutral from Outperform at Daiwa

TIPRANKS
·
Feb 12

Protalix BioTherapeutics Showcases Pipeline Advancements and Innovations in Rare Disease Therapies

Reuters
·
Feb 12

Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships

Simply Wall St.
·
Feb 12

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Reuters
·
Feb 11

Pfizer Inc. Publishes Transcript of Q4 2025 Earnings Call Event

Reuters
·
Feb 11